• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.

作者信息

Kanis J A, Geusens P, Christiansen C

机构信息

Department of Human Metabolism & Clinical Biochemistry, University of Sheffield Medical School, UK.

出版信息

Osteoporos Int. 1991 Jun;1(3):182-8. doi: 10.1007/BF01625451.

DOI:10.1007/BF01625451
PMID:1790407
Abstract
摘要

相似文献

1
Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.骨质疏松症临床试验指南。欧洲骨质疏松症与骨病基金会立场文件。
Osteoporos Int. 1991 Jun;1(3):182-8. doi: 10.1007/BF01625451.
2
Comparison of the European and USA practice guidelines for Osteoporosis.欧洲与美国骨质疏松症诊疗指南比较
Trends Endocrinol Metab. 2000 Jan-Feb;11(1):28-32. doi: 10.1016/s1043-2760(99)00214-3.
3
Guidelines on the Diagnosis of Osteoporosis and Assessment of Fracture Risk in Poland of III Central European Congress on Osteoporosis and Osteoarthritis, XV Congress of the Polish Osteoarthrology Society and Polish Foundation of Osteoporosis.第三届中欧骨质疏松与骨关节炎大会、波兰骨关节炎学会第十五届大会及波兰骨质疏松基金会发布的《波兰骨质疏松症诊断与骨折风险评估指南》
Ortop Traumatol Rehabil. 2010 Mar-Apr;12(2):194-200.
4
Should the treatment of osteoporosis be more selective?
Osteoporos Int. 2003 Apr;14(2):99-102. doi: 10.1007/s00198-002-1366-z. Epub 2003 Mar 12.
5
Guidelines for osteoporosis trials.骨质疏松症试验指南。
J Rheumatol. 1997 Jun;24(6):1234-6.
6
Discrimination of changes in osteoporosis outcomes.
J Rheumatol. 2001 Feb;28(2):413-21.
7
Osteoporosis: therapeutic guidelines. Guidelines for practice management of osteoporosis.骨质疏松症：治疗指南。骨质疏松症实践管理指南。
Clin Obstet Gynecol. 2013 Dec;56(4):694-702. doi: 10.1097/01.grf.0000437016.19989.61.
8
Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.儿童白血病和淋巴瘤患者的骨质疏松/骨量减少症的治疗。
Ann Pharmacother. 2009 Apr;43(4):714-20. doi: 10.1345/aph.1L567. Epub 2009 Mar 31.
9
Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF).骨质疏松症治疗药物临床评估建议：代表美国骨与矿物质研究学会（ASBMR）、国际临床骨密度测量学会（ISCD）和美国国家骨质疏松基金会（NOF）的专家小组共识
J Bone Miner Res. 2008 Jan;23(1):159-65. doi: 10.1359/jbmr.070905.
10
[Current research in adequate treatment by Osteoporosis Research Group].[骨质疏松症研究小组关于充分治疗的当前研究]
Clin Calcium. 2006 Sep;16(9):1500-7.

引用本文的文献

1
How Long to Treat with Denosumab.地诺单抗治疗时长
Curr Osteoporos Rep. 2015 Dec;13(6):415-20. doi: 10.1007/s11914-015-0295-7.
2
Sclerostin: therapeutic horizons based upon its actions.骨硬化蛋白：基于其作用的治疗前景。
Curr Osteoporos Rep. 2012 Mar;10(1):64-72. doi: 10.1007/s11914-011-0089-5.
3
Validation of the Japanese Osteoporosis Quality of Life Questionnaire.验证日本骨质疏松症生活质量问卷。
J Bone Miner Metab. 2010;28(1):1-7. doi: 10.1007/s00774-009-0125-z.
4
Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach.近期发生临床骨折且患有骨质疏松症患者的评估：一种多学科方法。
BMC Musculoskelet Disord. 2008 Aug 5;9:109. doi: 10.1186/1471-2474-9-109.
5
An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.参照国际临床骨密度学会（ISCD）、国际骨质疏松基金会（IOF）和美国国家骨质疏松基金会（NOF）指南对骨密度测量实践进行的一项审核。
Osteoporos Int. 2006;17(7):1111-5. doi: 10.1007/s00198-006-0101-6. Epub 2006 May 3.
6
Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures.新发椎体骨折对患有陈旧性椎体骨折的绝经后女性健康相关生活质量（HRQOL）的影响。
Osteoporos Int. 2005 Aug;16(8):861-70. doi: 10.1007/s00198-004-1774-3. Epub 2004 Nov 19.
7
The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.脆性骨折对健康相关生活质量的影响：抗骨折治疗的重要性。
Drugs Aging. 2004;21(11):711-30. doi: 10.2165/00002512-200421110-00002.
8
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos).在加拿大多中心骨质疏松症研究（CaMos）中，通过健康效用指数衡量的骨质疏松性骨折与健康相关生活质量之间的关联。
Osteoporos Int. 2003 Nov;14(11):895-904. doi: 10.1007/s00198-003-1483-3. Epub 2003 Aug 12.
9
Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: a meta-analysis of published clinical trials.降钙素与依替膦酸治疗绝经后骨质疏松症的比较：已发表临床试验的荟萃分析
Osteoporos Int. 1997;7(3):165-74. doi: 10.1007/BF01622285.
10
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.骨质疏松症治疗中的生活质量结局：欧洲骨质疏松症基金会生活质量问卷的编制
Osteoporos Int. 1997;7(1):36-8. doi: 10.1007/BF01623457.